There are 2789 resources available
1652P - Safety of simultaneously performed radiotherapy in patients with small cell lung cancer undergoing atezolizumab treatment
Presenter: Julia Galuba
Session: ePoster Display
1653P - Assessment of PD-L1 expression on circulating tumor cells (CTCs) and immune cells in peripheral blood of patients with small cell lung cancer (SCLC)
Presenter: Maria A Papadaki
Session: ePoster Display
1654P - A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression
Presenter: Zoran Andric
Session: ePoster Display
1799TiP - HGCSG2002: A prospective multicenter observational biomarker study of microbiome for nivolumab treatment in advanced esophageal cancer
Presenter: Shintaro Nakano
Session: ePoster Display
1690P - A multicenter randomized phase II open label study to compare the safety and efficacy of direct oral anticoagulants versus subcutaneous dalteparin for cancer-associated venous thromboembolism in patients with advanced upper gastrointestinal, hepatobiliary and pancreatic cancer
Presenter: Jwa Hoon Kim
Session: ePoster Display
1691P - Thromboembolic disease and immunotherapy in lung cancer
Presenter: David Fernandez Garay
Session: ePoster Display
1692P - Thromboprophylaxis in high-risk oncology patients: Is it a safe and effective clinical decision-intervention?
Presenter: Nikolaos Tsoukalas
Session: ePoster Display
1609P - COVID-19 outbreak repercussions on breast cancer diagnoses and access to treatment: Preliminary data from the COVID-DELAY study
Presenter: Rossana Berardi
Session: ePoster Display
1694P - Coffee and tea consumption (CTC), patient-reported (PRO), and clinical outcomes in a longitudinal study of patients (pts) with breast cancer (BC)
Presenter: Davide Soldato
Session: ePoster Display
1695P - ePRO follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care
Presenter: Sanna Iivanainen
Session: ePoster Display